These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 1622627

  • 1. Effect of estrogen and antiestrogens on cell proliferation and synthesis of secreted proteins in the human breast cancer cell line MCF-7 and a tamoxifen resistant variant subline, AL-1.
    Lykkesfeldt AE, Sørensen EK.
    Acta Oncol; 1992; 31(2):131-8. PubMed ID: 1622627
    [Abstract] [Full Text] [Related]

  • 2. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE, Madsen MW, Briand P.
    Cancer Res; 1994 Mar 15; 54(6):1587-95. PubMed ID: 8137264
    [Abstract] [Full Text] [Related]

  • 3. Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment.
    Lykkesfeldt AE, Larsen SS, Briand P.
    Int J Cancer; 1995 May 16; 61(4):529-34. PubMed ID: 7759159
    [Abstract] [Full Text] [Related]

  • 4. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N, Boysen B, Jirus S, Skaar TC, Holst-Hansen C, Lippman J, Frandsen T, Spang-Thomsen M, Fuqua SA, Clarke R.
    Cancer Res; 1997 Aug 15; 57(16):3486-93. PubMed ID: 9270017
    [Abstract] [Full Text] [Related]

  • 5. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells.
    Coopman P, Garcia M, Brünner N, Derocq D, Clarke R, Rochefort H.
    Int J Cancer; 1994 Jan 15; 56(2):295-300. PubMed ID: 8314314
    [Abstract] [Full Text] [Related]

  • 6. An estrogen receptor positive MCF-7 clone that is resistant to antiestrogens and estradiol.
    Jiang SY, Wolf DM, Yingling JM, Chang C, Jordan VC.
    Mol Cell Endocrinol; 1992 Dec 15; 90(1):77-86. PubMed ID: 1301400
    [Abstract] [Full Text] [Related]

  • 7. ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness.
    Thompson EW, Katz D, Shima TB, Wakeling AE, Lippman ME, Dickson RB.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):6929-34. PubMed ID: 2582435
    [Abstract] [Full Text] [Related]

  • 8. Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells.
    Watts CK, Sweeney KJ, Warlters A, Musgrove EA, Sutherland RL.
    Breast Cancer Res Treat; 1994 Dec 15; 31(1):95-105. PubMed ID: 7981461
    [Abstract] [Full Text] [Related]

  • 9. Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells.
    Poulin R, Merand Y, Poirier D, Levesque C, Dufour JM, Labrie F.
    Breast Cancer Res Treat; 1989 Oct 15; 14(1):65-76. PubMed ID: 2605344
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
    Gong Y, Ballejo G, Murphy LC, Murphy LJ.
    Cancer Res; 1992 Apr 01; 52(7):1704-9. PubMed ID: 1551100
    [Abstract] [Full Text] [Related]

  • 11. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation.
    Zhou-Li F, Albaladejo V, Joly-Pharaboz MO, Nicolas B, Andre J.
    Endocrinology; 1992 Mar 01; 130(3):1145-52. PubMed ID: 1537281
    [Abstract] [Full Text] [Related]

  • 12. Activity of tamoxifen and new antiestrogens on estrogen receptor positive and negative breast cancer cells.
    Coradini D, Biffi A, Cappelletti V, Di Fronzo G.
    Anticancer Res; 1994 Mar 01; 14(3A):1059-64. PubMed ID: 8074450
    [Abstract] [Full Text] [Related]

  • 13. Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator.
    Juncker-Jensen A, Lykkesfeldt AE, Worm J, Ralfkiaer U, Espelund U, Jepsen JS.
    Growth Horm IGF Res; 2006 Aug 01; 16(4):224-39. PubMed ID: 16893667
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium.
    Jensen J, Kitlen JW, Briand P, Labrie F, Lykkesfeldt AE.
    J Steroid Biochem Mol Biol; 2003 Mar 01; 84(4):469-78. PubMed ID: 12732292
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen.
    Herman ME, Katzenellenbogen BS.
    J Steroid Biochem Mol Biol; 1996 Oct 01; 59(2):121-34. PubMed ID: 9010327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.